A Case of Robot-Assisted Laparoscopic Radical Prostatectomy in Primary Small Cell Prostate Cancer

Kim, Ki Hong; Park, Sang Un; Jang, Jee Young; Park, Won Kyu; Oh, Cheol Kyu; Rha, Koon Ho

doi:10.4111/kju.2010.51.12.882

Cited by 2 publications

(1 citation statement)

References 9 publications

(10 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We conducted univariable analysis and multivariable analysis of data from published studies [6][7][8][9][10][11][12][13][14][15][16][17] (Table 3) and our studies including those who were age > 75, with the presence of distant metastases and who had undergone chemotherapy. The median age for all cases was 66 years.…”

Section: Resultsmentioning

confidence: 99%

Pure Small Cell Carcinoma of Prostate: A Report of 8 Cases

Zhang¹,

Ouyang²,

Sun³

et al. 2018

Urol Int

View full text Add to dashboard Cite

Purpose: To describe characteristics of pure small cell carcinoma of prostate (SCCP) and assess the prognostic factors. Patients and Methods: We summarized data of pure SCCP from published studies and ours and made Kaplan-Meier analysis and Cox regression to evaluate prognosis factors. Results: A total of 2,213 patients with prostate cancer was identified, of which eight (0.36%) patients were pure SCCP. The mean age at diagnosis was 61 years old. And there were 2 patients diagnosed at 34 and 50 years old respectively. Symptoms of these patients were similar to patients with prostate adenocarcinoma. Serum prostate specific antigen of 7 patients was at normal level. Five patients received chemotherapy, average overall survival (OS) was 9.75 months; 3 only received conservative treatment, average OS was 4 months. By univariate and multivariate Cox analysis, chemotherapy is an independent predictor of survival. Kaplan-Meier analysis demonstrated that chemotherapy was associated with longer OS. Conclusion: Clinical characteristics, examination and treatment strategy of pure SCCP are very different from prostate adenocarcinoma. According to the data from published studies and from our studies, the average survival of patients receiving chemotherapy is longer than those who received other treatment modalities.

show abstract

Section: Resultsmentioning

confidence: 99%

Pure Small Cell Carcinoma of Prostate: A Report of 8 Cases

Zhang¹,

Ouyang²,

Sun³

et al. 2018

Urol Int

View full text Add to dashboard Cite

show abstract

Complete Chemotherapeutic Regression of a Non-Metastatic Case of Primary Pure Small Cell Carcinoma of the Prostate

Yahyazadeh

Abadpour²,

Molanaei

et al. 2012

Current Urology

View full text Add to dashboard Cite

Pure small cell carcinoma of the prostate (SCPCa) is a very rare condition usually with poor survival after diagnosis. It seems to show different clinical features compared to other prostate cancer subtypes, specifically adenocarcinoma. Here, we present a 74-year-old man early diagnosed with SCPCa treated with a cisplatine and etoposide regimen. There was no metastasis found in imaging studies and bone scan. The patient mostly complained of obstructive symptoms which were relieved after resection. Interestingly, our patient experienced a disease free condition after chemotherapy and no further progression was found. This could implicate the critical role of early diagnosis in the treatment of SCPCa despite its aggressive nature.

show abstract

A Case of Robot-Assisted Laparoscopic Radical Prostatectomy in Primary Small Cell Prostate Cancer

Cited by 2 publications

References 9 publications

Pure Small Cell Carcinoma of Prostate: A Report of 8 Cases

Pure Small Cell Carcinoma of Prostate: A Report of 8 Cases

Complete Chemotherapeutic Regression of a Non-Metastatic Case of Primary Pure Small Cell Carcinoma of the Prostate

Contact Info

Product

Resources

About